Back to Search
Start Over
Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial.
- Source :
-
European urology [Eur Urol] 2024 Jan; Vol. 85 (1), pp. 97-98. Date of Electronic Publication: 2023 Sep 28. - Publication Year :
- 2024
- Subjects :
- Humans
Antineoplastic Combined Chemotherapy Protocols
Immune Checkpoint Inhibitors therapeutic use
Multicenter Studies as Topic
Randomized Controlled Trials as Topic
Clinical Trials, Phase III as Topic
Anilides therapeutic use
Carcinoma, Renal Cell drug therapy
Kidney Neoplasms drug therapy
Kidney Neoplasms pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1873-7560
- Volume :
- 85
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- European urology
- Publication Type :
- Academic Journal
- Accession number :
- 37777426
- Full Text :
- https://doi.org/10.1016/j.eururo.2023.09.011